Implication of inflammatory markers in post Covid syndrome
Bibliographic Data
| ID | 15799640 |
|---|---|
| Authors | Rohit Rohit (0009-0004-0819-8290, Marymount University), Manvi Sharma (0000-0003-2708-4403, corresponding author), Mayank Nangru (corresponding author), Ankit Gulia (Public Works Department Buildings and Roads, corresponding author) |
| Year | 2023 |
| Volume | 7 |
| Issue | S1 |
| Pages | 2644-2651 |
| Publication date | 2023-09-15 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Health Sciences (JOURNAL) |
| Journal identifiers | ISSN: 2550-696X • E-ISSN: 2550-6978 |
| Publisher | Universidad Tecnica de Manabi (PUBLISHER • EC) |
| DOI | 10.53730/ijhs.v7ns1.14558 |
| OpenAlex | W4386785834 |
| Language | EN |
Post-COVID syndrome was described in the context of a survey of prolonged COVID-19 symptoms for the first time in 2020, run by the Patient-Led Research Collaborative, citizen’s scientist group. Symptoms persisting for more than three weeks after the diagnosis of COVID-19 fall into the category of post-COVID syndrome. The most common post-COVID symptoms include fatigue, dyspnea, olfactory and gustatory dysfunction, chest pain, myalgia, and sleep and mental disorders. The pathogenesis of post-COVID syndrome is multi-factorial. Underlying chronic, low grade inflammation has been theorized for pathogenesis. Available data shows conflicting results regarding the implication of inflammatory markers in full clinical spectrum and its long-term outcome
2019-20 coronavirus outbreak · Context (archaeology · Coronavirus disease 2019 (COVID-19 · Disease · myalgia · Outbreak · Pathogenesis · Pathology · Physical therapy · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · COVID-19 Clinical Research Studies · Inflammasome and immune disorders · Long-Term Effects of COVID-19 · Medicine · Internal Medicine
| Highly cited | No |
|---|